WallStSmart

Haoxi Health Technology Limited Class A Ordinary Shares (HAO)vsMagnite Inc (MGNI)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Magnite Inc generates 1593% more annual revenue ($722.55M vs $42.68M). MGNI leads profitability with a 22.0% profit margin vs -6.5%. MGNI earns a higher WallStSmart Score of 70/100 (B-).

HAO

Hold

49

out of 100

Grade: D+

Growth: 8.7Profit: 2.0Value: 5.0Quality: 9.0
Piotroski: 4/9Altman Z: 5.80

MGNI

Strong Buy

70

out of 100

Grade: B-

Growth: 7.3Profit: 6.0Value: 9.3Quality: 5.5
Piotroski: 4/9Altman Z: 0.37
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

Intrinsic value data unavailable for HAO.

MGNIUndervalued (+49.4%)

Margin of Safety

+49.4%

Fair Value

$23.30

Current Price

$14.68

$8.62 discount

UndervaluedFair: $23.30Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

HAO5 strengths · Avg: 9.8/10
Price/BookValuation
0.0x10/10

Reasonable price relative to book value

Revenue GrowthGrowth
41.2%10/10

Revenue surging 41.2% year-over-year

EPS GrowthGrowth
172.7%10/10

Earnings expanding 172.7% YoY

Altman Z-ScoreHealth
5.8010/10

Safe zone — low bankruptcy risk

Debt/EquityHealth
0.109/10

Conservative balance sheet, low leverage

MGNI6 strengths · Avg: 9.2/10
PEG RatioValuation
0.0910/10

Growing faster than its price suggests

EPS GrowthGrowth
230.0%10/10

Earnings expanding 230.0% YoY

Debt/EquityHealth
0.0910/10

Conservative balance sheet, low leverage

Profit MarginProfitability
22.0%9/10

Keeps 22 of every $100 in revenue as profit

P/E RatioValuation
13.7x8/10

Attractively priced relative to earnings

Price/BookValuation
2.3x8/10

Reasonable price relative to book value

Areas to Watch

HAO4 concerns · Avg: 2.0/10
Market CapQuality
$1.97M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
-15.5%2/10

ROE of -15.5% — below average capital efficiency

Free Cash FlowQuality
$-2.27M2/10

Negative free cash flow — burning cash

Profit MarginProfitability
-6.5%1/10

Currently unprofitable

MGNI3 concerns · Avg: 2.3/10
Operating MarginProfitability
4.7%3/10

Operating margin of 4.7%

Free Cash FlowQuality
$-130.17M2/10

Negative free cash flow — burning cash

Altman Z-ScoreHealth
0.372/10

Distress zone — elevated risk

Comparative Analysis Report

WallStSmart Research

Bull Case : HAO

The strongest argument for HAO centers on Price/Book, Revenue Growth, EPS Growth. Revenue growth of 41.2% demonstrates continued momentum.

Bull Case : MGNI

The strongest argument for MGNI centers on PEG Ratio, EPS Growth, Debt/Equity. Profitability is solid with margins at 22.0% and operating margin at 4.7%. PEG of 0.09 suggests the stock is reasonably priced for its growth.

Bear Case : HAO

The primary concerns for HAO are Market Cap, Return on Equity, Free Cash Flow.

Bear Case : MGNI

The primary concerns for MGNI are Operating Margin, Free Cash Flow, Altman Z-Score.

Key Dynamics to Monitor

HAO profiles as a hypergrowth stock while MGNI is a mature play — different risk/reward profiles.

MGNI carries more volatility with a beta of 2.32 — expect wider price swings.

HAO is growing revenue faster at 41.2% — sustainability is the question.

HAO generates stronger free cash flow (-2M), providing more financial flexibility.

Bottom Line

MGNI scores higher overall (70/100 vs 49/100), backed by strong 22.0% margins. Both earn "Strong Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Haoxi Health Technology Limited Class A Ordinary Shares

COMMUNICATION SERVICES · ADVERTISING AGENCIES · USA

Haoxi Health Technology Limited Class A Ordinary Shares is a pioneering force in the health technology sector, focused on revolutionizing healthcare delivery through innovative solutions. Utilizing advanced technologies, including artificial intelligence and data analytics, the company significantly improves diagnostic accuracy, treatment efficiency, and patient management. With a robust commitment to research and development, Haoxi is well-positioned to capitalize on emerging trends in healthcare technology, presenting considerable growth opportunities for institutional investors looking to engage in this dynamic market.

Magnite Inc

COMMUNICATION SERVICES · ADVERTISING AGENCIES · USA

Magnite, Inc. operates an independent sales advertising platform in the United States and internationally. The company is headquartered in Los Angeles, California.

Want to dig deeper into these stocks?